Genetic models to progress treatments for IQSEC2 related pharmacoresistant epilepsy.
Awardee: Cheryl Shoubridge
Institution: University of Adelaide
Grant Amount: $30,000
Funding Period: March 1, 2024 - February 28, 2025
Summary: This project aims to generate patient derived iPS cells modelling the loss of IQSEC2 to comprehensively evaluate anti-epileptic drugs in reducing seizure activity in a human relevant setting.